Clinical Study

Utility of Nuclear Morphometry in Predicting Grades of Diffusely Infiltrating Gliomas

Table 1

Mean values of age and nuclear parameters of the two study and the control groups with their standard deviation and range. values between each pair of group for all the parameters.

Parameters (unit) ± SD
(min–max)
Group (no. of cases) value
CG (10)LGG (14)HGG (16) (CG versus LGG) (CG versus HGG) (LGG versus HGG)

Age (year) ± SD
(min–max)
46.3 ± 3.5
(40–53)
39.1 ± 14.1
(9–62)
54.6 ± 16.8
(27–79)
0.1335*0.1397*0.0116

MAJX ( m) ± SD
(min–max)
6.96 ± 0.59
(6.23–8.07)
9.41 ± 0.81
(7.51–10.30)
10.73 ± 1.33
(8.90–12.87)
<0.0001<0.00010.0032

MINX ( m) ± SD
(min–max)
4.62 ± 0.35
(4.18–5.30)
6.34 ± 0.70
(4.98–7.56)
7.11 ± 0.94
(4.66–8.70)
<0.0001<0.00010.0184

NA ( m2) ± SD
(min–max)
23.44 ± 4.01
(19.42–30.33)
42.62 ± 7.26
(27.15–55.23)
55.22 ± 13.48
(30.26–76.90)
<0.0001<0.00010.0042

NP ( m) ± SD
(min–max)
21.54 ± 2.11
(18.84–25.33)
29.79 ± 2.80
(23.34–32.74)
34.24 ± 4.49
(28.92–41.91)
<0.0001<0.00010.0034

NR (%) ± SD
(min–max)
65.55 ± 4.34
(59.85–73.48)
61.53 ± 5.42
(48.99–70.43)
59.78 ± 5.80
(48.94–70.40)
0.0659*0.01250.4011*

ND (per mm2) ± SD
(min–max)
1107 ± 138
(849–1282)
3232 ± 1596
(1456–5633)
4350 ± 1089
(1941–6360)
<0.0004<0.00010.0314

%TNA2.32 ± 0.54
(1.65–3.33)
9.98 ± 4.34
(3.63–17.35)
15.88 ± 7.48
(6.64–35.33)
<0.0001<0.00010.0151

CG: control group; LGG: low-grade gliomas; HGG: high-grade gliomas; min: minimum; max: maximum; (X versus Y): value between X group versus Y group by Student's unpaired -test; *: difference is not significant.